LY262691
LY262691 is a selective CCK-B antagonist with antipsychotic properties. LY262691 decreases the number of spontaneously active A9 and A10 dopamine cells and can be utilized in antipsychotic research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 138932-35-1
- Formel: C22H18BrN3O2
- Molecular Weight:436.30
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 138932-35-1
-
Molecular Weight 436.30
-
Formel C22H18BrN3O2
-
SMILES
BrC(C=C1)=CC=C1NC(N2[C@@H](C3=CC=CC=C3)[C@H](C4=CC=CC=C4)C(N2)=O)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)